Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access

The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma

Ghaneh, Paula MD∗,†; Kleeff, Jorg MD; Halloran, Christopher M. MD; Raraty, Michael MD; Jackson, Richard PhD; Melling, James MD; Jones, Owain MD; Palmer, Daniel H. MD; Cox, Trevor F. PhD; Smith, Chloe J. MSc; O’Reilly, Derek A. MD; Izbicki, Jakob R. MD§; Scarfe, Andrew G. MD; Valle, Juan W. MD||; McDonald, Alexander C. MD∗∗; Carter, Ross MD††; Tebbutt, Niall C. PhD‡‡; Goldstein, David MB§§; Padbury, Robert MB¶¶; Shannon, Jennifer PhD, FRACP||||; Dervenis, Christos MD∗∗∗; Glimelius, Bengt MD†††; Deakin, Mark MD‡‡‡; Anthoney, Alan MD§§§; Lerch, Markus M. MD¶¶¶; Mayerle, Julia MD¶¶¶; Oláh, Attila MD||||||; Rawcliffe, Charlotte L. MSc; Campbell, Fiona MD∗∗∗∗; Strobel, Oliver MD††††; Büchler, Markus W. MD††††; Neoptolemos, John P. MD∗,†; for the European Study Group for Pancreatic Cancer

Author Information
doi: 10.1097/SLA.0000000000002557
  • Buy
  • SDC


Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.